Skip to Content

AB Global Risk Allocation R CBSRX Fund Analysis

| Medalist Rating as of | See AllianceBernstein Investment Hub

Morningstar’s Analysis CBSRX

Will CBSRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit AB Global Risk Allocation R to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor